On December 9, 2021 Bavarian Nordic A/S (OMX: BAVA) ("Bavarian Nordic" or the "Company") reported that it has in connection with the directed issue and private placement registered with the Danish Business Authority, a capital increase of a nominal value of DKK 63,736,800 (6,373,680 shares of DKK 10 each) (the "New Shares"), representing 9.94% of the registered share capital prior to the capital increase (the "Offering") (Press release, Bavarian Nordic, DEC 9, 2021, View Source [SID1234596688]).
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
The New Shares have been issued under a temporary ISIN code and are expected to be admitted to trading and official listing under the permanent ISIN code DK0015998017 on Nasdaq Copenhagen A/S with effect from 10 December 2021. After registration of the share capital increase, the share capital of Bavarian Nordic amounts to nominally DKK 704,683,930 divided into 70,468,393 shares of DKK 10 each. The total number of voting rights in Bavarian Nordic are 70,468,393.
The New Shares rank pari passu with the Company’s existing shares and carry the same dividend and other rights. Each New Share carries one vote at the Company’s general meetings.
Reference is made to company announcements no. 40 and 41 of 6 December 2021.
The amendments to the Company’s articles of association required by the capital increase have been registered today with the Danish Business Authority and an updated version can be found at bavarian-nordic.com.
JOINT GLOBAL COORDINATORS AND JOINT BOOKRUNNERS
Citigroup Global Markets Limited and Nordea Danmark, filial af Nordea Bank Abp, Finland acted as Joint Global Coordinators and Joint Bookrunners in connection with the Offering (jointly the "Joint Global Coordinators and Joint Bookrunners").
Kromann Reumert and Latham & Watkins LLP acted as Danish and U.S. legal advisors respectively to the Company. Plesner acted as Danish legal advisors to the Joint Global Coordinators and Joint Bookrunners.